{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:17:32Z","timestamp":1793042252032,"version":"4.5.0"},"reference-count":152,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaci.2024.10.007","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T13:55:21Z","timestamp":1729259721000},"page":"1343-1354","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Upper airway comorbidities of asthma"],"prefix":"10.1016","volume":"154","author":[{"given":"Chang-Gyu","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M.","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Bochenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Dzoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0933-953X","authenticated-orcid":false,"given":"Seong Ho","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2024.10.007_bib1","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1016\/j.jaip.2021.08.028","article-title":"Asthma and comorbid conditions\u2014pulmonary comorbidity","volume":"9","author":"Gibson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib2","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1016\/j.jaip.2021.08.027","article-title":"Nonrespiratory comorbidities in asthma","volume":"9","author":"Cardet","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/02770903.2017.1316394","article-title":"Asthma control and disease burden in patients with asthma and allergic comorbidities","volume":"55","author":"Lee","year":"2018","journal-title":"J Asthma"},{"key":"10.1016\/j.jaci.2024.10.007_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/alr.23090","article-title":"International consensus statement on allergy and rhinology: allergic rhinitis - 2023","volume":"13","author":"Wise","year":"2023","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.10.007_bib5","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.10.007_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhin20.401","article-title":"European position paper on rhinosinusitis and nasal polyps 2020","volume":"58","author":"Fokkens","year":"2020","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.10.007_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4168\/aair.2012.4.4.171","article-title":"Recent developments in united airways disease","volume":"4","author":"Ciprandi","year":"2012","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2024.10.007_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/17476348.2017.1381564","article-title":"The role of upper airway pathology as a co-morbidity in severe asthma","volume":"11","author":"Licari","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.otc.2022.09.005","article-title":"Unified airway disease: examining prevalence and treatment of upper airway eosinophilic disease with comorbid asthma","volume":"56","author":"Mehta","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.jaci.2024.10.007_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13133721","article-title":"Upper airway alarmin cytokine expression in asthma of different severities","volume":"13","author":"Marriott","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/JAA.S81541","article-title":"United airway disease: current perspectives","volume":"9","author":"Giavina-Bianchi","year":"2016","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib12","article-title":"Pre-asthma: a useful concept for prevention and disease-modification? A\u00a0EUFOREA paper. Part 1-allergic asthma","volume":"4","author":"Scadding","year":"2023","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2024.1404735","article-title":"Pre-asthma: a useful concept? A\u00a0EUFOREA paper. Part 2-late onset eosinophilic asthma","volume":"5","author":"Scadding","year":"2024","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib14","article-title":"Chronic\u00a0rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma","volume":"2","author":"Castillo","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaci.2024.10.007_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12130","article-title":"Worldwide prevalence of rhinitis in adults: a review of definitions and temporal evolution","volume":"12","author":"Savour\u00e9","year":"2022","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-7022-1-2","article-title":"Diagnostic tools in rhinology EAACI position paper","volume":"1","author":"Scadding","year":"2011","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/all.13200","article-title":"Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology","volume":"72","author":"Hellings","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib18","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/cea.12953","article-title":"BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (revised edition 2017; first edition 2007)","volume":"47","author":"Scadding","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib19","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jaci.2012.02.032","article-title":"Local allergic rhinitis: concept, pathophysiology, and management","volume":"129","author":"Rond\u00f3n","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib20","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaip.2024.04.021","article-title":"Local allergic rhinitis","volume":"12","author":"Campo","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib21","first-page":"364","article-title":"Local allergic rhinitis: concept, clinical manifestations, and diagnostic approach","volume":"20","author":"Rondon","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jaci.2023.02.014","article-title":"Nasal allergen challenge (NAC): practical aspects and applications from an EU\/US perspective-a work group report of the AAAAI Rhinitis, Rhinosinusitis and Ocular Allergy Committee","volume":"151","author":"Cho","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib23","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1038\/s41598-022-10448-w","article-title":"Association of rhinitis with asthma prevalence and severity","volume":"12","author":"Acevedo-Prado","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2024.10.007_bib24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/all.15679","article-title":"Rhinitis associated with asthma is distinct from rhinitis alone: the ARIA-MeDALL hypothesis","volume":"78","author":"Bousquet","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib25","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00408-009-9179-x","article-title":"Time interval and the factors associated with the development of asthma in patients with allergic rhinitis","volume":"187","author":"Mahesh","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.jaci.2024.10.007_bib26","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1067\/mai.2000.110151","article-title":"Epidemiologic evidence for asthma and rhinitis comorbidity","volume":"106","author":"Leynaert","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1067\/mai.2002.121701","article-title":"Rhinitis as an independent risk factor for adult-onset asthma","volume":"109","author":"Guerra","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2500\/108854194778816634","article-title":"Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students","volume":"15","author":"Settipane","year":"1994","journal-title":"Allergy Proc"},{"key":"10.1016\/j.jaci.2024.10.007_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1034\/j.1399-3003.1999.14d28.x","article-title":"Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis","volume":"14","author":"Gratziou","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.007_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13223-019-0388-4","article-title":"Does unified allergic airway disease impact on\u00a0lung function and type 2 biomarkers?","volume":"15","author":"Kuo","year":"2019","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib31","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/pai.12326","article-title":"Exhaled nitric oxide in children with allergic rhinitis: a potential biomarker of asthma development","volume":"26","author":"Di Cara","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib32","article-title":"Transcriptomic analysis of asthma and allergic rhinitis reveals CST1 as a biomarker of unified airways","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib33","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/all.14582","article-title":"Biomarkers for diagnosis and prediction of therapy responses in allergic diseases and asthma","volume":"75","author":"Breiteneder","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib34","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1111\/all.14970","article-title":"Genetic variants in the TLR-related pathway and smoking exposure alter the upper airway microbiota in adult asthmatic patients","volume":"76","author":"Losol","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib35","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.4110\/in.2021.21.e19","article-title":"The role of upper airway microbiome in the development of adult asthma","volume":"21","author":"Losol","year":"2021","journal-title":"Immune Netw"},{"key":"10.1016\/j.jaci.2024.10.007_bib36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(08)61446-4","article-title":"Rhinitis and onset of asthma: a longitudinal population-based study","volume":"372","author":"Shaaban","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.10.007_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/cea.13276","article-title":"Non-atopic rhinitis at age 6 is associated with subsequent development of asthma","volume":"49","author":"Carr","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11882-022-01027-0","article-title":"Clinical evidence of type 2 inflammation in non-allergic rhinitis with eosinophilia syndrome: a systematic review","volume":"22","author":"De Corso","year":"2022","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaci.2024.10.007_bib39","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ijporl.2012.08.013","article-title":"Cell-mediated non-allergic rhinitis in children","volume":"76","author":"Maselli Del Giudice","year":"2012","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jaci.2024.10.007_bib40","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/all.13272","article-title":"Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study","volume":"73","author":"Rondon","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib41","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.rmed.2006.06.006","article-title":"Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon","volume":"101","author":"Marcucci","year":"2007","journal-title":"Respir Med"},{"issue":"suppl\u00a086","key":"10.1016\/j.jaci.2024.10.007_bib42","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jaci.2008.05.001","article-title":"Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes","volume":"122","author":"Anderson","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib44","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.jaci.2003.09.051","article-title":"Systemic effects of local allergic disease","volume":"113","author":"Togias","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib45","first-page":"27","article-title":"Regulation of interaction between the upper and lower airways in united airway disease","volume":"7","author":"Kanda","year":"2019","journal-title":"Med Sci (Basel)"},{"key":"10.1016\/j.jaci.2024.10.007_bib46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2013.08.026","article-title":"Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis","volume":"133","author":"Van Gerven","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib47","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1016\/j.jaip.2020.06.047","article-title":"Occupational rhinitis","volume":"8","author":"Vandenplas","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Bro\u017cek","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/lary.27576","article-title":"Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma","volume":"129","author":"De Corso","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaci.2024.10.007_bib50","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2018.08.049","article-title":"Allergic rhinitis and its impact on asthma (ARIA) phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology","volume":"143","author":"Bousquet","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib51","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI guidelines on allergen immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib52","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2020.07.036","article-title":"A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: an international, double-blind, placebo-controlled, randomized phase III clinical trial","volume":"147","author":"Demoly","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib53","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2024.10.007_bib54","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib55","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1016\/j.jaip.2021.08.018","article-title":"Efficacy of Subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison","volume":"9","author":"Kim","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib56","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/all.15042","article-title":"High-dose pollen intralymphatic immunotherapy: two RDBPC trials question the benefit of dose increase","volume":"77","author":"Hellkvist","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib57","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1056\/NEJMoa2212895","article-title":"Phase 3 trial of epicutaneous immunotherapy in toddlers with peanut allergy","volume":"388","author":"Greenhawt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib58","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaip.2022.09.010","article-title":"Nonallergic rhinitis, allergic rhinitis, and immunotherapy: advances in the last decade","volume":"11","author":"Ponda","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib60","article-title":"Upper airway disease diagnosis as a predictive biomarker of therapeutic response to biologics in severe asthma","volume":"10","author":"Cottin","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaci.2024.10.007_bib61","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib62","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.chest.2016.03.018","article-title":"Phase 3 study of reslizumab in patients with poorly controlled asthma: effects across a broad range of eosinophil counts","volume":"150","author":"Corren","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaci.2024.10.007_bib63","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor \u03b1 monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.10.007_bib64","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib65","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1513\/AnnalsATS.202010-1249OC","article-title":"A comprehensive analysis of the stability of blood eosinophil levels","volume":"18","author":"Chipps","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaci.2024.10.007_bib66","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04590-2020","article-title":"Blood eosinophil counts in the general population and airways disease: a comprehensive review and meta-analysis","volume":"59","author":"Benson","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.007_bib67","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1001\/jama.286.23.2956","article-title":"Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial","volume":"286","author":"Casale","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2024.10.007_bib68","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1081-1206(10)62171-0","article-title":"Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis","volume":"91","author":"Chervinsky","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaip.2014.02.001","article-title":"Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials","volume":"2","author":"Tsabouri","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1945892419884774","article-title":"Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials","volume":"34","author":"Yu","year":"2020","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2017.11.051","article-title":"Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma","volume":"142","author":"Weinstein","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib72","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/all.12124","article-title":"Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis","volume":"68","author":"Lohia","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib73","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0091-6749(96)70150-1","article-title":"Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis","volume":"98","author":"Foresi","year":"1996","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.jaci.2024.10.007_bib74","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2466-6-S1-S4","article-title":"Allergic rhinitis: evidence for impact on asthma","volume":"6","author":"Thomas","year":"2006","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib75","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.jaip.2022.01.016","article-title":"Epidemiology of chronic rhinosinusitis: prevalence and risk factors","volume":"10","author":"Sedaghat","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib76","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaip.2018.10.014","article-title":"Clinical characteristics of patients with chronic rhinosinusitis without nasal polyps in an academic setting","volume":"7","author":"Benjamin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib77","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jamaoto.2015.3142","article-title":"Prevalence and risk factors of chronic rhinosinusitus, allergic rhinitis, and nasal septal deviation: results of the Korean National Health and Nutrition Survey 2008-2012","volume":"142","author":"Ahn","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaci.2024.10.007_bib78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2500\/ar.2015.6.0120","article-title":"Commentary on gender differences in prevalence, treatment, and quality of life of patients with chronic rhinosinusitis","volume":"6","author":"Ference","year":"2015","journal-title":"Allergy Rhinol (Providence)"},{"key":"10.1016\/j.jaci.2024.10.007_bib79","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1017\/S0022215107001302","article-title":"Impact of gender on clinical presentation of chronic rhinosinusitis with and without polyposis","volume":"122","author":"Busaba","year":"2008","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jaci.2024.10.007_bib80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib81","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/alr.22428","article-title":"Benefits and harms of aspirin desensitization for aspirin-exacerbated respiratory disease: a systematic review and meta-analysis","volume":"9","author":"Chu","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaci.2024.10.007_bib82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5414\/ALX02475E","article-title":"EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP)","volume":"8","author":"Hagemann","year":"2024","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaci.2024.10.007_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.08.011","article-title":"Severe eosinophilic asthma or eosinophilic granulomatosis with polyangitis: potential biomarkers for novel diagnostic strategies","author":"Latorre","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib84","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/j.jaci.2022.02.016","article-title":"Mechanisms and pathogenesis of chronic rhinosinusitis","volume":"149","author":"Kato","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib85","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/all.15074","article-title":"Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches","volume":"77","author":"Kato","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib86","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib87","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2016.05.041","article-title":"Diversity of TH cytokine profiles in patients with chronic rhinosinusitis: a multicenter study in Europe, Asia, and Oceania","volume":"138","author":"Wang","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.anai.2018.02.005","article-title":"Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset","volume":"120","author":"Won","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fped.2019.00256","article-title":"Asthma in children and adults-what are the differences and what can they tell us about asthma?","volume":"7","author":"Trivedi","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaci.2024.10.007_bib90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaip.2019.11.024","article-title":"Eosinophilic asthma","volume":"8","author":"Nelson","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-018-0823-y","article-title":"Prevalence\u00a0of\u00a0asthma, aspirin sensitivity and allergy in chronic rhinosinusitis: data from the UK National Chronic Rhinosinusitis Epidemiology Study","volume":"19","author":"Philpott","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2024.10.007_bib92","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/all.12222","article-title":"Chronic rhinosinusitis in asthma is a negative predictor of quality of life: results from the Swedish GA(2)LEN survey","volume":"68","author":"Ek","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib93","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1164\/rccm.201602-0419OC","article-title":"Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations","volume":"195","author":"Denlinger","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib94","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib95","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib96","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2024.10.007_bib97","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jaip.2016.04.015","article-title":"Chronic rhinosinusitis without nasal polyps","volume":"4","author":"Cho","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib98","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jaip.2016.03.010","article-title":"Allergic fungal rhinosinusitis","volume":"4","author":"Hoyt","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib99","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/1945892420912159","article-title":"Indications and outcomes for patients with limited symptoms undergoing endoscopic sinus surgery","volume":"34","author":"Rahman","year":"2020","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaci.2021.07.045","article-title":"Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study","volume":"149","author":"Gevaert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib101","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2021.08.030","article-title":"Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A\u00a0randomized, placebo-controlled trial","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib102","doi-asserted-by":"crossref","first-page":"419","DOI":"10.18176\/jiaci.0939","article-title":"Improvement in smell using monoclonal antibodies among patients with chronic rhinosinusitis with nasal polyps: a systematic review","volume":"33","author":"Barroso","year":"2023","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaip.2022.10.030","article-title":"A decade of clinical advances in chronic rhinosinusitis: 2012\u20132022","volume":"11","author":"Naclerio","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib104","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1111\/all.14526","article-title":"Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation","volume":"75","author":"Hong","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib105","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.jaip.2021.07.023","article-title":"The choice of biologics in patients with severe chronic\u00a0rhinosinusitis with nasal polyps","volume":"9","author":"Lipworth","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib106","first-page":"283","article-title":"Biologicals in severe chronic rhinosinusitis with nasal polyps: translation to clinical practice while waiting for head-to-head studies","volume":"61","author":"Boechat","year":"2023","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.10.007_bib107","first-page":"194","article-title":"EPOS\/EUFOREA update on indication and evaluation of biologics in chronic rhinosinusitis with nasal polyps 2023","volume":"61","author":"Fokkens","year":"2023","journal-title":"Rhinology"},{"key":"10.1016\/j.jaci.2024.10.007_bib108","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.anai.2021.01.012","article-title":"Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma","volume":"126","author":"Laidlaw","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib109","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib110","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.007_bib111","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jaip.2019.12.021","article-title":"Phenotypes of chronic rhinosinusitis","volume":"8","author":"Cho","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib112","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib113","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/all.12629","article-title":"NSAID-exacerbated respiratory disease: a meta-analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity","volume":"70","author":"Morales","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2500\/ajra.2011.25.3660","article-title":"The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors","volume":"25","author":"Bavbek","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib115","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib116","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1081-1206(10)61323-3","article-title":"Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease","volume":"94","author":"Mascia","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib117","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jaip.2016.12.027","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib118","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2500\/ajr.2006.20.2913","article-title":"Medical and surgical considerations in patients with Samter's triad","volume":"20","author":"McMains","year":"2006","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaci.2024.10.007_bib119","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib120","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib121","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.jaci.2012.04.016","article-title":"Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease","volume":"129","author":"Stevenson","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib122","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.jaip.2020.06.061","article-title":"Leukotriene-associated rash in aspirin-exacerbated respiratory disease","volume":"8","author":"Laidlaw","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib123","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D\u2082: a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib124","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.jaip.2018.12.014","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in patients with aspirin exacerbated respiratory disease","volume":"7","author":"Jerschow","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib125","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/j.jaip.2019.02.037","article-title":"Sinus surgery improves lower respiratory tract reactivity during aspirin desensitization for AERD","volume":"7","author":"Huang","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib126","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib127","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2022.08.021","article-title":"Updates on immune mechanisms in aspirin-exacerbated respiratory disease","volume":"151","author":"Laidlaw","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib128","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.jaci.2021.08.015","article-title":"Eicosanoid dysregulation and type 2 inflammation in AERD","volume":"148","author":"Mullol","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib129","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jaci.2020.11.001","article-title":"Inflammatory heterogeneity in aspirin-exacerbated respiratory disease","volume":"147","author":"Scott","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib130","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaip.2022.03.021","article-title":"Utility of nasal mucus inflammatory profile as a biomarker of nasal polyp regrowth in aspirin-exacerbated respiratory disease","volume":"10","author":"Corey","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib131","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib132","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/1945892418770260","article-title":"Long-term clinical outcomes of aspirin desensitization with continuous daily aspirin therapy in aspirin-exacerbated respiratory disease","volume":"32","author":"Walters","year":"2018","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib133","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","article-title":"The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: a work group report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy","volume":"147","author":"Stevens","year":"2021","journal-title":"Asthma & Immunology. J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib134","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1939-4551-7-18","article-title":"Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease","volume":"7","author":"Howe","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2024.10.007_bib135","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jaip.2021.12.030","article-title":"Controversies in allergy: aspirin desensitization or biologics for aspirin-exacerbated respiratory disease-how to choose","volume":"10","author":"Laidlaw","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib136","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaip.2023.09.019","article-title":"Should biologics be used before aspirin desensitization in aspirin-exacerbated respiratory disease?","volume":"12","author":"Laidlaw","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib137","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.anai.2023.05.016","article-title":"Aspirin-exacerbated respiratory disease: updates in the era of biologics","volume":"131","author":"Mullur","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib138","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1016\/j.jaip.2022.04.039","article-title":"Management of united airway disease focused on patients with asthma and chronic rhinosinusitis with nasal polyps: a systematic review","volume":"10","author":"Mullol","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib139","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/all.15067","article-title":"Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: results from two randomized placebo-controlled phase 3 trials","volume":"77","author":"Mullol","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib140","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib141","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2022.04.007","article-title":"Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease","volume":"150","author":"Buchheit","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib142","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1945892420961969","article-title":"Dupilumab as add-on therapy for chronic rhinosinusitis with nasal polyposis in aspirin exacerbated respiratory disease","volume":"35","author":"Mustafa","year":"2021","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib143","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01335-2022","article-title":"Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease","volume":"61","author":"Schneider","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2024.10.007_bib144","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/19458924211030486","article-title":"Defining the efficacy of omalizumab in nasal polyposis: a POLYP 1 and POLYP 2 subgroup analysis","volume":"36","author":"Damask","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaci.2024.10.007_bib145","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.201906-1215OC","article-title":"Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease. a randomized controlled trial","volume":"201","author":"Hayashi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaci.2024.10.007_bib146","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaip.2021.09.050","article-title":"Omalizumab-induced aspirin tolerance in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease patients is independent of atopic sensitization","volume":"10","author":"Quint","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib147","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.jaci.2021.10.040","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps: treatment efficacy by comorbidity and blood eosinophil count","volume":"149","author":"Bachert","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib148","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaip.2018.01.038","article-title":"A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease","volume":"6","author":"Tuttle","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib149","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.anai.2022.01.043","article-title":"Aspirin desensitization and biologics in aspirin-exacerbated respiratory disease: efficacy, tolerability, and patient experience","volume":"128","author":"Mullur","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaci.2024.10.007_bib150","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jaip.2020.09.007","article-title":"Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: a case series","volume":"9","author":"Martin","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib151","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.jaip.2023.04.033","article-title":"Nonsteroidal anti-inflammatory drug (NSAID) tolerance after biological therapy in patients with nsaid-exacerbated respiratory disease: a randomized comparative trial","volume":"11","author":"S\u00e1nchez","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2024.10.007_bib152","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaip.2021.09.030","article-title":"Appraisal of the real-world effectiveness of biologic therapies in aspirin-exacerbated respiratory disease","volume":"10","author":"Wangberg","year":"2022","journal-title":"J Allergy Clin Immunol Pract"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924010649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674924010649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T07:42:08Z","timestamp":1733298128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674924010649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":152,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0091674924010649"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2024.10.007","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upper airway comorbidities of asthma","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2024.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}